A 56-year-old man was brought into our primary percutaneous coronary intervention (PCI) centre with a suspected acute myocardial infarction (AMI).

He presented with a 3-week history of anosmia, hypogeusia, lethargy, fever, and persistent cough, culminating in acute-onset chest pain and syncope. In 2017, he had suffered an anterior AMI, undergoing PCI to the left anterior descending artery. This was complicated by a left ventricular (LV) thrombus that resolved with 12 months of anticoagulation, which was then discontinued. The 12-lead electrocardiogram (ECG) did not show ST-segment elevation, and bedside echocardiography failed to produce cardiac imaging from standard views. On examination, he was hypotensive (82/60 mmHg) and hypoxic (SpO~2~ 88%) with unequal chest expansion and reduced air entry on the left.

An urgent chest radiograph confirmed a left-sided spontaneous tension pneumothorax (*Panel A*). He had an emergency surgical chest drain resulting in immediate clinical improvement. D-dimer was elevated (7480 ng/mL). The computed tomography pulmonary angiogram (CTPA) showed subsegmental pulmonary emboli (*Panel B*, asterisks), residual pneumothorax with surgical emphysema, and bilateral consolidation in bronchocentric and peripheral distributions, associated with traction bronchiectasis (*Panel C*). An apical LV thrombus (28 × 21 × 18 mm) was also identified, as demonstrated by multiplanar 3D image reconstruction (*Panels D* and *E*, arrowhead) and transthoracic echocardiography ([Supplementary material online, *Video 1*](#sup1){ref-type="supplementary-material"}). Anticoagulation was commenced and he was discharged home after complete resolution of the pneumothoax. His initial SARS-CoV-2 PCR was negative but he subsequently tested positive on day 4.

This is the first reported case of a spontaneous pneumothorax associated with multiple thrombotic complications of COVID-19. It highlights the importance of recognizing life-threatening and multisystemic manifestations of COVID-19 in patients presenting to a PCI centre.
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